Source: Annual Congress 2006 - Common and differing aspects of acute and chronic lung injury
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Nathani, G. Perkins, A. Richter, D. Thickett (Birmingham, United Kingdom). KL-6 as a marker of alveolar inflammation in patients with ARDS. Eur Respir J 2006; 28: Suppl. 50, 3712

Member's Comments

No comment yet.

Related content which might interest you: KL-6/MUC1 in interstitial pneumonia Source: Annual Congress 2005 - Lung-specific serum markers for interstitial lung diseases Year: 2005 KL-6 in whole lung lavage fluid of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 HRCT-score and markers of fibrosis in BAL in DPLD patients Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 BAL markers of alveolar/capillary abnormality in IPF Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Serum SP-A as predictor of disease progression in patients with pulmonary alveolar proteinosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012 Plasma CRP levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome? Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation Year: 2008 Human napsin a is a useful serum marker of interstitial lung disease, compared to KL-6, and surfactant protein-D Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Serum KL-6 identifies ILD patients with a progressive fibrosing phenotype Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Serum concentrations of KL-6 in patients with IPF and lung cancer and serial measurements of KL-6 in IPF patients treated with antifibrotic therapy Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation Source: Eur Respir J 2013; 41: 396-401 Year: 2013 Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis Source: Annual Congress 2004 - Fibrosing lung diseases Year: 2004 KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Corticosteroid increased apoptosis of airway sputum macrophages from patients with COPD and emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001 The influence of acute respiratory tract infection on the serum levels of KL-6 and SP-D in chronic interstitial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 825s Year: 2006 KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome Source: Eur Respir J 2004; 23: 142-145 Year: 2004 The effect of tenascin-c deficiency on TGF-β-mediated fibrosis and alveolar inflammation in a murine model of ARDS Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Calgranulin B/S100A9 and KL-6 in bronchoalveolar lavage of patients with IPF and NSIP. Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 RAGE expression in lung tissue of ARDS and septic patients Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020 Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs Source: Eur Respir J 2007; 29: 1105-1114 Year: 2007